Stock Research for AMMJ

AMMJ

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AMMJ Stock Chart & Research Data

The AMMJ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AMMJ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AMMJ Due diligence Resources & Stock Charts

The AMMJ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AMMJ Detailed Price Forecast - CNN Money CNN View AMMJ Detailed Summary - Google Finance
Yahoo View AMMJ Detailed Summary - Yahoo! Finance Zacks View AMMJ Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AMMJ Trends & Analysis - Trade-Ideas Barrons View AMMJ Major Holders - Barrons
NASDAQ View AMMJ Call Transcripts - NASDAQ Seeking View AMMJ Breaking News & Analysis - Seeking Alpha
Spotlight View AMMJ Annual Report - CompanySpotlight.com OTC Report View AMMJ OTC Short Report - OTCShortReport.com
TradeKing View AMMJ Fundamentals - TradeKing Charts View AMMJ SEC Filings - Bar Chart
WSJ View Historical Prices for AMMJ - The WSJ Morningstar View Performance/Total Return for AMMJ - Morningstar
MarketWatch View the Analyst Estimates for AMMJ - MarketWatch CNBC View the Earnings History for AMMJ - CNBC
StockMarketWatch View the AMMJ Earnings - StockMarketWatch MacroAxis View AMMJ Buy or Sell Recommendations - MacroAxis
Bullish View the AMMJ Bullish Patterns - American Bulls Short Pains View AMMJ Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AMMJ Stock Mentions - StockTwits PennyStocks View AMMJ Stock Mentions - PennyStockTweets
Twitter View AMMJ Stock Mentions - Twitter Invest Hub View AMMJ Investment Forum News - Investor Hub
Yahoo View AMMJ Stock Mentions - Yahoo! Message Board Seeking Alpha View AMMJ Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AMMJ - SECform4.com Insider Cow View Insider Transactions for AMMJ - Insider Cow
CNBC View AMMJ Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AMMJ - OTC Markets
Yahoo View Insider Transactions for AMMJ - Yahoo! Finance NASDAQ View Institutional Holdings for AMMJ - NASDAQ


Stock Charts

FinViz View AMMJ Stock Insight & Charts - FinViz.com StockCharts View AMMJ Investment Charts - StockCharts.com
BarChart View AMMJ Stock Overview & Charts - BarChart Trading View View AMMJ User Generated Charts - Trading View




Latest Financial News for AMMJ


American Cannabis Company, Inc. Announces Exclusive Contract to Manufacture and Distribute Her Highness Branded Products in Colorado
Posted on Thursday May 13, 2021

DENVER, CO, May 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce that it has finalized an exclusive manufacturing and distribution agreement with Her Highness NYC (“Her Highness”) within the state of Colorado. Her Highness features premier designer cannabis products and accessories designed and engineered thoughtfully for women by women who are passionate and determined to expand the ever-growing market of female consumers. “Securing this opportunity with Her Highness marks a significant accomplishment for American Cannabis Company,” said Terry Buffalo, Chief Executive Officer of American Cannabis Company. Buffalo continued, “Our team is very excited and enthusiastic to launch Her Highness in Colorado. For many years there has been a gap in this industry, as most products have been marketed to male-focused demographics. With female consumers making up a large portion of the market, brands like Her Highness have established themselves to provide premier products that are made to deliver experiences that elevate and celebrate women.” The Her Highness collection of products include bespoke long crutch pre-roll cones packed in gold boxes with refillable gold lighters, the brand’s famous “highly orgasmic” Pleasure Oil, gluten free 2.5mg micro-dose THC mints, luxuriously engineered gold Giggle and High Priestess vape pens, deluxe ashtrays constructed with marble and brass, gold tone luxe herb grinders and elegant smoking accessories. Allison Krongard, co-founder of Her Highness, also commented: “As a New York-based brand, we could not be more excited and honored to bring our cannabis collection to Colorado, ground-zero for regulated cannabis. Through its retail channels as well as via the wholesale market, American Cannabis Company will be providing consumers with our catalog of female-forward cannabis couture.” Laura Eisman, co-founder of Her Highness, also commented: “We’re thrilled to have ACC as a licensing partner as we look to expand into additional legal markets throughout the US and internationally. With a mission to introduce and educate women on the benefits of cannabis, we aim to offer products tailored to enhance the experience of life. The future of cannabis is feminine, and we are at the forefront.” About American Cannabis Company, Inc. American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions. For more information about American Cannabis Company, please visit: www.theacclife.com www.americancannabisconsulting.com www.americancannabiscompanyinc.com www.sohumsoils.com www.americanhempservices.com Video Links: https://americancannabisconsulting.com/resources/video/ (ACC Site) https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System) https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube) https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®) About Her Highness Backed by Merida Capital, Her Highness is a female-first lifestyle cannabis brand based in New York, designed for the modern cannabis consumer. With an elevated brand aesthetic, a sophisticated collection of cannabis and CBD products and stylish consumption accessories, Her Highness is created for the feminine lifestyle. Her Highness’ accessories and CBD line retails online with their THC line available in California, Nevada, Massachusetts and soon, Colorado, Pennsylvania and Ohio. Curated with female-friendly effects like clear head, sans-munchies, anxiety-free and high-functioning, Her Highness products are developed to benefit women, addressing specific needs in their daily lives. Through a partnership with the Last Prisoner Project, Her Highness raises funds for women with non-violent cannabis convictions working towards or reentering after release. For more information about Her Highness, please visit: www.herhighness.com @herhighnessnyc on all social platforms ACC Contact: IR@americancannabisconsulting.com 303-974-4770 Her Highness Media Contact: info@melissaavitale.com Forward-Looking Statements This news release contains "forward-looking statements," which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan". These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov. Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug. In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated. Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws. Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks. On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.


American Cannabis Company, Inc. Receives Approval from Colorado’s Marijuana Enforcement Division (MED) and the City of Colorado Springs to Acquire, Own, and Operate Naturaleaf™ in Southern Colorado
Posted on Tuesday May 04, 2021

DENVER, CO, May 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce that on April 30, 2021, Colorado’s Marijuana Enforcement Division (MED) and the City of Colorado Springs granted regulatory approvals for the Company’s acquisition and operation of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., all doing business as Naturaleaf™, a long-standing vertically integrated cannabis business. As a result of the regulatory approvals and the closing of the asset purchase, the Company acquired Naturaleaf’s three medically licensed retail stores, and a 10,000 square foot cultivation and extraction facility located in the metropolitan area of Colorado Springs. Naturaleaf™ has earned a strong reputation for its quality products and customer experience, having served its loyal and growing patient base since 2009. “We are incredibly happy to have completed this acquisition, and this is only the beginning,” said Terry Buffalo, Chief Executive Officer of American Cannabis Company. Buffalo continued, “With the approval from the regulatory bodies now behind us, this is where the real work starts. Brand integration is key for success, and our team is working diligently to dial in processes and procedures, as well as implementing ACC’s company culture and core values, while also maintaining Naturaleaf™ brand integrity. We look to expand production capacities by revamping the cultivation operation, adding technology and equipment, including our proprietary cultivation methodologies and ‘just add water’ all-natural potting mix, SoHum Living Soils®, to effectively grow a consistent, high-value flower product. In addition to the modifications we plan to make in the back of the house, we also aim to elevate the retail experience by adding best-in-market products, new retail equipment and technologies to maximize customer/patient experience, as well as maintain consistent inventories. With this acquisition we anticipate over $2mm+ in gross revenue, and we look to increase upon that. For more details, please read the Company’s most recent 8-K filings.” Scott Saunders, owner of Naturaleaf™, commented: “We are happy to have been acquired by American Cannabis Company. Since 2009 Naturaleaf has been pioneering the local medical market. The staff is excited to transition under the ownership of a public company, and I am excited for the people of Colorado Springs to see what American Cannabis Company is going to bring to the local community.” Overall Transaction Background On December 10, 2020, American Cannabis Company announced that it had executed a non-binding letter of intent to acquire all three (3) Naturaleaf™ medical marijuana centers along with its ten thousand (10,000) square foot commercial cultivation facility that also includes non-volatile extraction facilities. On March 11, 2021, American Cannabis Company announced that it had executed the official Asset Purchase Agreement (APA) and on April 20, 2021 the Company received a contingent approval letter from Colorado’s Marijuana Enforcement Division (MED), outlining the change of ownership. After now having obtained final regulatory approval transferring the Naturaleaf™ licenses to the Company, and finalizing the closing of the asset purchase transaction as of April 30, 2021, the Company plans to acquire additional local and national cannabis assets and brands, with the goal of creating a portfolio of cannabis assets elevating the consumer experience through a commitment to wellness, quality products, and cleaner green practices. For a complete disclosure of the asset purchase agreement, see the Company’s Form 8-K filed with the Securities and Exchange Commission: https://www.sec.gov/Archives/edgar/data/945617/000172186821000142/f2sammj8k031121.htm For a complete disclosure of the acquisition for Naturaleaf™ and the received regulatory approval, see the Company’s Form 8-K filed with the Securities and Exchange Commission: https://www.sec.gov/Archives/edgar/data/945617/000172186821000254/f2sammj8k043021.htm About American Cannabis Company, Inc. American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions. For more information about American Cannabis Company, please visit: www.theacclife.com www.americancannabisconsulting.com www.americancannabiscompanyinc.com www.sohumsoils.com www.americanhempservices.com Video Links: https://americancannabisconsulting.com/resources/video/ (ACC Site) https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System) https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube) https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®) About Naturaleaf™ Naturaleaf™, a well-known brand frequently sought out by locals in the Colorado Springs area, has been providing medical patients with cannabis and cannabis-derived products for over ten (10) years. Its staff and patient specialists maintain a very active presence in the local community, strive to find patients the right medicine for present or given conditions, and promote cannabis education to its patrons in a one-on-one retail concierge experience. For more information on Naturaleaf™, please visit: www.thenaturaleaf.com Contact: IR@americancannabisconsulting.com 303-974-4770 Forward-Looking Statements This news release contains "forward-looking statements," which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan". These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov. Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug. In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated. Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws. Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks. On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.


American Cannabis Company, Inc. Announces Formation of Advisory Board
Posted on Thursday March 18, 2021

DENVER, CO, March 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce its newly formed Advisory Board consisting of cannabis and non-cannabis sector professionals, who will provide guidance relating to the Company’s strategic plans and initiatives, and highlight potential key areas of opportunity within the industry for ACC and its portfolio of brand assets to capitalize upon. Terry Buffalo, CEO of American Cannabis Company, commented: “We are thrilled to be officially launching the ACC Advisory Board. The Executive Team has taken several months to carefully compile a list of top professionals who each bring unique strengths and backgrounds to the table. We are proud to say that we have selected these seven (7) individuals as our inaugural members.” Advisory Board Members include*: Christine Comatos Elvin Moon Karen Thomas Peggy Moore Breck Speed Greg Shoenfeld Carolyn Burek *for Member-specific bios, please visit: https://americancannabisconsulting.com/about/advisory-board/ Buffalo continued, “As a public company that is solidifying itself as a long-standing player in the cannabis industry, the team and I wanted to develop an advisory group of individuals who we felt could provide their respective insights in parallel with the deployment of our strategies for brand asset growth and expansion. We look forward to working closely with this group and will continue to evaluate additional member candidates as our growth trajectory progresses.” About American Cannabis Company, Inc. American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions. For more information about American Cannabis Company, please visit: www.theacclife.com www.americancannabisconsulting.com www.americancannabiscompanyinc.com www.sohumsoils.com www.americanhempservices.com Video Links: https://americancannabisconsulting.com/resources/video/ (ACC Site) https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System) https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube) https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®) Contact: IR@americancannabisconsulting.com 303-974-4770 Forward-Looking Statements This news release contains "forward-looking statements," which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan". These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov. Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug. In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated. Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws. Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks. On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.


American Cannabis Company, Inc. Executes Definitive Agreement to Acquire Naturaleaf™ in Southern Colorado
Posted on Tuesday March 16, 2021

DENVER, CO, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce that on March 11, 2021, it executed a material definite agreement to acquire the assets and operations of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., all doing business as Naturaleaf™, located in the metropolitan area of Colorado Springs, Colorado. A long-standing and reputable medical cannabis retailer in a thriving market, Naturaleaf™ operates three licensed medical marijuana centers, including a 10,000 square foot cultivation facility containing non-volatile extraction facilities, and has provided patients with quality cannabis, cannabis-derived products and related accessories for over ten (10) years. “For over a decade, Naturaleaf™ has built a brand name that truly speaks for itself. Providing medical quality cannabis and products to its loyal customer base of registered patients through a one-on-one retail concierge experience, this acquisition is something that our team is excited for as we look to improve the overall business performance and increase revenues while maintaining brand integrity,” said Terry Buffalo, CEO of American Cannabis Company. Buffalo continued, “Through the due diligence process our team identified key performance indicators that we will use as a baseline to improve revenue, operational costs, and identify market trends as a means to fulfill the ever-growing demand. We expect this acquisition to bring in over $2.2mm in gross revenue, and we look to increase upon that. For more details, please read the Company’s most recent 8-K filing. All of the documents required to be filed to complete transfer of the licenses have been filed with the appropriate regulatory agencies, and we anticipate closing the transaction after final regulatory approval, which we expect in the second quarter.” Scott Saunders, owner of Naturaleaf™, commented: “We are very happy to have Naturaleaf™ join the American Cannabis Company portfolio of brand assets. The staff is excited to transition under the ownership of a public company as this industry continues to emerge and expand, and I am excited for the people of Colorado Springs and Southern Colorado to see what American Cannabis Company can do to a brand that the team and I have spent years building.” Transaction Background On December 10, 2020, American Cannabis Company announced that it had executed a non-binding letter of intent to acquire all three (3) Naturaleaf™ medical marijuana centers along with its ten thousand (10,000) square foot commercial cultivation facility that also includes non-volatile extraction facilities. After obtaining final regulatory approval transferring the Naturaleaf™ licenses to the Company, and finalizing the closing of the asset purchase transaction, the Company plans to acquire additional local and national cannabis assets and brands, with the goal of creating a portfolio of cannabis assets elevating the consumer experience through a commitment to wellness, quality products, and cleaner green practices. For a complete disclosure of the asset purchase agreement, see the Company’s Form 8-K filed with the Securities and Exchange Commission: https://www.sec.gov/Archives/edgar/data/945617/000172186821000142/f2sammj8k031121.htm About American Cannabis Company, Inc. American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions. For more information about American Cannabis Company, please visit: www.theacclife.com www.americancannabisconsulting.com www.americancannabiscompanyinc.com www.sohumsoils.com www.americanhempservices.com Video Links: https://americancannabisconsulting.com/resources/video/ (ACC Site) https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System) https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube) https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®) For more information on Naturaleaf™, please visit: www.thenaturaleaf.com Contact: IR@americancannabisconsulting.com 303-974-4770 Forward-Looking Statements This news release contains "forward-looking statements," which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan". These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov. Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug. In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated. Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws. Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks. On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.